Sector valuations Dr. Lal PathLabs Limited
Stocks
LALPATHLAB
INE600L01024
Healthcare Facilities & Services
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,693.30 INR | +0.35% |
|
-1.84% | +14.21% |
| Jun. 17 | Dr. Lal PathLabs' Volume Boom Comes at a Cost | |
| May. 04 | Nomura Adjusts Dr. Lal PathLabs' Price Target to INR1,860 From INR1,800, Keeps at Buy | MT |
Main competitors
| P/E (Y) | Price to Book (Y) | PEG (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| 47.89x | 9.96x | 3.01x | 8.51x | 30.23x | 37.73x | 1.09% | 2.93B | ||
| -162.94x | 20.57x | -17.01x | 13.52x | -184.09x | -148.64x | -.--% | 38.87B | ||
| 19.53x | 2.47x | 0.5x | 1.89x | 10.91x | 12.87x | 1.03% | 23.24B | ||
| 17.59x | 1.24x | 1.06x | 1.36x | 7.73x | 14.15x | 4.96% | 7.55B | ||
| 318.92x | - | -1.79x | - | - | - | - | 4.89B | ||
| -32.78x | - | 0.7x | - | - | - | -.--% | 1.9B | ||
| -18.98x | - | -0.05x | - | - | - | - | 1.88B | ||
| 34.16x | 1.76x | -0.11x | 1.59x | 12.66x | 20.97x | 1.49% | 1.8B | ||
| 13.04x | 1.74x | 0.96x | 1.34x | 5.26x | 8.99x | 5.8% | 1.76B | ||
| 28.64x | 1.68x | 0.04x | 1.01x | 8.46x | 12.34x | 0.88% | 1.65B | ||
| 80.56x | 14.47x | 4.11x | 16.77x | 41.4x | 56.44x | 0.13% | 1.43B | ||
| 56.49x | 7.78x | 1.52x | 6.76x | 27.89x | 40.32x | 0.37% | 1.17B | ||
| 32.95x | 1.38x | -2.14x | 0.81x | 6.7x | 22.92x | 3.69% | 1.15B | ||
| -3.93x | 0.52x | -3.94x | 0.95x | - | -2.4x | - | 899M | ||
| 42.16x | 12.97x | 2.06x | - | - | - | 2.07% | 860M | ||
| 18.06x | 1.04x | -14.2x | - | - | - | 3.44% | 838M | ||
| 24.68x | 1.85x | 0.96x | - | - | - | 0.39% | 760M | ||
| -42.99x | - | 1.44x | 181.7x | -39.63x | -37.63x | - | 598M | ||
| Average | 26.28x | 5.68x | -1.27x | 19.68x | -6.59x | 3.17x | 1.81% | 5.23B | |
| Weighted average by Cap. | -39.85x | 11.19x | -6.85x | 9.08x | -80.74x | -60.90x | 1.03% |
- Stock Market
- Stocks
- LALPATHLAB Stock
- Sector Dr. Lal PathLabs Limited
- Sector valuations
Select your edition
All financial news and data tailored to specific country editions
















